Gw Henssler & Associates LTD Novartis Ag Transaction History

Gw Henssler & Associates LTD

  • $1.76 Billion
  • Q3 2024

A detailed history of Gw Henssler & Associates LTD transactions in Novartis Ag stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 250,878 shares of NVS stock, worth $24.7 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
250,878
Previous 249,225 0.66%
Holding current value
$24.7 Million
Previous $26.5 Million 8.76%
% of portfolio
1.64%
Previous 1.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$106.13 - $120.89 $175,432 - $199,831
1,653 Added 0.66%
250,878 $28.9 Million
Q2 2024

Aug 01, 2024
BUY
$92.57 - $107.37 $55,449 - $64,314
599 Added 0.24%
249,225 $26.5 Million
Q1 2024

May 07, 2024
BUY
$95.27 - $108.47 $133,378 - $151,858
1,400 Added 0.57%
248,626 $24 Million
Q4 2023

Jan 26, 2024
BUY
$92.27 - $101.54 $958,777 - $1.06 Million
10,391 Added 4.39%
247,226 $25 Million
Q3 2023

Oct 24, 2023
SELL
$94.73 - $105.13 $32,492 - $36,059
-343 Reduced 0.14%
236,835 $24.1 Million
Q2 2023

Aug 02, 2023
SELL
$92.52 - $104.91 $17.5 Million - $19.8 Million
-188,711 Reduced 44.31%
237,178 $23.9 Million
Q1 2023

Apr 26, 2023
BUY
$80.03 - $92.81 $576,296 - $668,324
7,201 Added 1.72%
425,889 $39.2 Million
Q4 2022

Feb 03, 2023
BUY
$75.55 - $92.52 $593,596 - $726,929
7,857 Added 1.91%
418,688 $38 Million
Q3 2022

Nov 04, 2022
BUY
$74.61 - $87.26 $2.13 Million - $2.49 Million
28,523 Added 7.46%
410,831 $31.2 Million
Q2 2022

Aug 04, 2022
BUY
$80.52 - $93.75 $12.6 Million - $14.6 Million
156,187 Added 69.07%
382,308 $32.3 Million
Q1 2022

May 09, 2022
BUY
$80.11 - $90.62 $1.44 Million - $1.63 Million
17,967 Added 8.63%
226,121 $19.8 Million
Q4 2021

Jan 28, 2022
SELL
$79.7 - $88.13 $57,702 - $63,806
-724 Reduced 0.35%
208,154 $18.2 Million
Q3 2021

Nov 02, 2021
BUY
$81.78 - $95.14 $1 Million - $1.17 Million
12,251 Added 6.23%
208,878 $17.1 Million
Q2 2021

Aug 09, 2021
BUY
$85.24 - $94.15 $653,279 - $721,565
7,664 Added 4.06%
196,627 $17.9 Million
Q1 2021

Apr 28, 2021
BUY
$83.5 - $98.47 $714,593 - $842,706
8,558 Added 4.74%
188,963 $16.2 Million
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $217,034 - $262,515
2,780 Added 1.57%
180,405 $17 Million
Q3 2020

Oct 22, 2020
BUY
$82.14 - $91.0 $474,276 - $525,434
5,774 Added 3.36%
177,625 $15.4 Million
Q2 2020

Jul 21, 2020
BUY
$80.93 - $91.1 $1.19 Million - $1.33 Million
14,645 Added 9.32%
171,851 $15 Million
Q1 2020

Apr 27, 2020
BUY
$70.67 - $99.01 $2.78 Million - $3.9 Million
39,354 Added 33.39%
157,206 $13 Million
Q4 2019

Feb 24, 2020
BUY
$84.35 - $95.37 $598,041 - $676,173
7,090 Added 6.4%
117,852 $11.2 Million
Q3 2019

Nov 18, 2019
BUY
$85.54 - $94.26 $190,155 - $209,539
2,223 Added 2.05%
110,762 $9.63 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $870,040 - $1.07 Million
11,539 Added 11.9%
108,539 $9.91 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $120,361 - $137,667
1,598 Added 1.68%
97,000 $9.33 Million
Q4 2018

Jan 22, 2019
BUY
$73.66 - $82.02 $307,898 - $342,843
4,180 Added 4.58%
95,402 $8.19 Million
Q3 2018

Oct 23, 2018
BUY
$66.94 - $77.43 $195,799 - $226,482
2,925 Added 3.31%
91,222 $7.86 Million
Q2 2018

Aug 06, 2018
BUY
$64.91 - $73.36 $315,916 - $357,043
4,867 Added 5.83%
88,297 $6.67 Million
Q1 2018

May 04, 2018
BUY
$70.39 - $84.15 $134,796 - $161,147
1,915 Added 2.35%
83,430 $6.75 Million
Q4 2017

Feb 06, 2018
BUY
$72.33 - $77.64 $343,278 - $368,479
4,746 Added 6.18%
81,515 $6.84 Million
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $5.69 Million - $5.93 Million
76,769
76,769 $6.59 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gw Henssler & Associates LTD Portfolio

Follow Gw Henssler & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email